---
title: "Canaccord Genuity Remains a Hold on National Bank of Canada (NTIOF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292017523.md"
description: "Canaccord Genuity analyst maintained a Hold rating on National Bank of Canada yesterday. The company’s shares closed yesterday at C$228.78.4th of July Sale - 70% Off Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. Currently, the analyst consensus on National Bank of Canada is a Moderate Buy with an average price target of $145.55."
datetime: "2026-07-08T05:35:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292017523.md)
  - [en](https://longbridge.com/en/news/292017523.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292017523.md)
---

# Canaccord Genuity Remains a Hold on National Bank of Canada (NTIOF)

Canaccord Genuity analyst maintained a Hold rating on National Bank of Canada yesterday. The company’s shares closed yesterday at C$228.78.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

Currently, the analyst consensus on National Bank of Canada is a Moderate Buy with an average price target of $145.55.

## Related News & Research

- [What I track in a day](https://longbridge.com/en/news/293769848.md)
- [Baylin receives CAD 1.7 million GaN amplifier order from US defense communications contractor](https://longbridge.com/en/news/293627044.md)
- [BMO announces July cash distributions for select ETFs, including ZAG at CAD 0.039 per unit](https://longbridge.com/en/news/293608697.md)
- [Gavin Newsom Says Trump's Canada Tariffs Will Raise Costs, Asks How Many 'Tantrums' Do Americans Have To Suffer Through](https://longbridge.com/en/news/293436833.md)
- [Valbiotis says REVERSE-IT trial results for Totum•63 published in Nature Communications](https://longbridge.com/en/news/293495212.md)